You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/76898
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoroz, Andrei-
dc.contributor.authorDeffune, Elenice-
dc.date.accessioned2014-05-27T11:30:52Z-
dc.date.accessioned2016-10-25T18:55:05Z-
dc.date.available2014-05-27T11:30:52Z-
dc.date.available2016-10-25T18:55:05Z-
dc.date.issued2013-11-01-
dc.identifierhttp://dx.doi.org/10.1016/j.jcyt.2013.05.019-
dc.identifier.citationCytotherapy, v. 15, n. 11, p. 1436-1439, 2013.-
dc.identifier.issn1465-3249-
dc.identifier.issn1477-2566-
dc.identifier.urihttp://hdl.handle.net/11449/76898-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/76898-
dc.description.abstractBackground: Platelet-rich plasma has been largely used as a therapeutic option for the treatment of chronic wounds of different etiologies. The enhanced regeneration observed after the use of platelet-rich plasma has been systematically attributed to the growth factors that are present inside platelets' granules. Aim: We hypothesize that the remaining plasma and platelet-bound fibronectin may act as a further bioactive protein in platelet-rich plasma preparations. Methods: Recent reports were analyzed and presented as direct evidences of this hypotheses. Results: Fibronectin may directly influence the extracellular matrix remodeling during wound repair. This effect is probably through matrix metalloproteinase expression, thus exerting an extra effect on chronic wound regeneration. Conclusions: Physicians should be well aware of the possible fibronectin-induced effects in their future endeavors with PRP in chronic wound treatment. © 2013 International Society for Cellular Therapy.en
dc.format.extent1436-1439-
dc.language.isoeng-
dc.sourceScopus-
dc.subjectChronic wounds-
dc.subjectExtracellular matrix-
dc.subjectFibronectin-
dc.subjectMMP-
dc.subjectPlatelet-rich plasma-
dc.subjectPRP-
dc.subjectWound regeneration-
dc.titlePlatelet-Rich Plasma And Chronic Wounds: Remaining Fibronectin May Influence Matrix Remodeling And Regeneration Successen
dc.typeoutro-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationBlood Transfusion Center, Cell Engineering Laboratory Botucatu Medical School Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.description.affiliationDepartment of Morphology, Extracellular Matrix Laboratory Botucatu Biosciences Institute Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.description.affiliationDepartment of Urology, Botucatu Medical School Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.description.affiliationUnespBlood Transfusion Center, Cell Engineering Laboratory Botucatu Medical School Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.description.affiliationUnespDepartment of Morphology, Extracellular Matrix Laboratory Botucatu Biosciences Institute Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.description.affiliationUnespDepartment of Urology, Botucatu Medical School Universidade Estadual Paulista-UNESP, Botucatu, SP-
dc.identifier.doi10.1016/j.jcyt.2013.05.019-
dc.identifier.wosWOS:000325732800013-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofCytotherapy-
dc.identifier.scopus2-s2.0-84884979717-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.